Bioasis Technologies Inc. (BIOAF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0002 (-99.50%)
At close: Jun 17, 2025
Bioasis Technologies Revenue
Bioasis Technologies had revenue of 148.94K CAD in the quarter ending November 30, 2022, with 294.79% growth. This brings the company's revenue in the last twelve months to 269.38K, up 614.05% year-over-year. In the fiscal year ending February 28, 2022, Bioasis Technologies had annual revenue of 37.73K, down -99.07%.
Revenue (ttm)
269.38K CAD
Revenue Growth
+614.05%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
79.00 USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2022 | 37.73K | -4.04M | -99.07% |
| Feb 28, 2021 | 4.08M | 3.47M | 572.53% |
| Feb 29, 2020 | 606.38K | -815.65K | -57.36% |
| Feb 28, 2019 | 1.42M | 832.19K | 141.09% |
| Feb 28, 2018 | 589.84K | 76.88K | 14.99% |
| Feb 28, 2017 | Pro | Pro | Pro |
| Feb 29, 2016 | Pro | Pro | Pro |
| Feb 28, 2015 | Pro | Pro | Pro |
| Feb 28, 2014 | Pro | Pro | Pro |
| Feb 28, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Bioasis Technologies News
- 2 years ago - Bioasis Provides Corporate Update and Announces Suspension of Operations - GlobeNewsWire
- 2 years ago - Bioasis Provides Update on Business Operations - GlobeNewsWire
- 2 years ago - Bioasis Announces AGM Results and Provides Update on Financial Position - GlobeNewsWire
- 2 years ago - Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc - GlobeNewsWire
- 2 years ago - Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022 - GlobeNewsWire
- 2 years ago - Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders - GlobeNewsWire
- 2 years ago - Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc - GlobeNewsWire
- 2 years ago - Bioasis Technologies Inc. Announces Shareholder Webinar - GlobeNewsWire